BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 16860939)

  • 21. [Kaposi's sarcoma].
    Imamura A
    Gan To Kagaku Ryoho; 2003 May; 30(5):634-9. PubMed ID: 12795094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AIDS-related Kaposi's sarcoma: state of the art and therapeutic strategies.
    Martellotta F; Berretta M; Vaccher E; Schioppa O; Zanet E; Tirelli U
    Curr HIV Res; 2009 Nov; 7(6):634-8. PubMed ID: 19929800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotherapy for AIDS-associated Kaposi's sarcoma.
    Kahn J; Northfelt D; Volberding P
    Oncology (Williston Park); 1991 Oct; 5(10):57-63; discussion 64, 67. PubMed ID: 1838275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NK cell activity controls human herpesvirus 8 latent infection and is restored upon highly active antiretroviral therapy in AIDS patients with regressing Kaposi's sarcoma.
    Sirianni MC; Vincenzi L; Topino S; Giovannetti A; Mazzetta F; Libi F; Scaramuzzi D; Andreoni M; Pinter E; Baccarini S; Rezza G; Monini P; Ensoli B
    Eur J Immunol; 2002 Oct; 32(10):2711-20. PubMed ID: 12355422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Kaposi's sarcoma].
    Boué F; Lebbé C
    Bull Cancer; 2003 May; 90(5):393-8. PubMed ID: 12850761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlled-release of doxorubicin from poly(lactide-co-glycolide) microspheres significantly enhances cytotoxicity against cultured AIDS-related Kaposi's sarcoma cells.
    Mallery SR; Pei P; Kang J; Ness GM; Ortiz R; Touhalisky JE; Schwendeman SP
    Anticancer Res; 2000; 20(5A):2817-25. PubMed ID: 11062689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of AIDS-related Kaposi's sarcoma.
    Northfelt DW; Kahn JO; Volberding PA
    Hematol Oncol Clin North Am; 1991 Apr; 5(2):297-310. PubMed ID: 2022595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Highly active antiretroviral therapy in AIDS-associated Kaposi's sarcoma (KS): implications for the design of therapeutic trials in patients with advanced symptomatic KS.
    Nasti G; Tirelli U
    J Clin Oncol; 2005 Apr; 23(10):2433; author reply 2433-4. PubMed ID: 15800341
    [No Abstract]   [Full Text] [Related]  

  • 29. Docetaxel in anthracycline-pretreated AIDS-related Kaposi's sarcoma: a retrospective study.
    Autier J; Picard-Dahan C; Marinho E; Grossin M; Yeni P; Leport C; Vildé JL; Crickx B; Descamps V
    Br J Dermatol; 2005 May; 152(5):1026-9. PubMed ID: 15888164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kaposi's sarcoma in AIDS.
    Volberding PA
    Immunol Ser; 1989; 44():345-58. PubMed ID: 2489116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome-related Kaposi sarcoma.
    Nasti G; Martellotta F; Berretta M; Mena M; Fasan M; Di Perri G; Talamini R; Pagano G; Montroni M; Cinelli R; Vaccher E; D'Arminio Monforte A; Tirelli U; ;
    Cancer; 2003 Dec; 98(11):2440-6. PubMed ID: 14635079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AIDS-associated Kaposi's sarcoma.
    Kahn JO; Northfelt DW; Miles SA
    AIDS Clin Rev; 1992; ():261-80. PubMed ID: 1606060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of AIDS-related Kaposi sarcoma: advances in target discovery and treatment.
    Dezube BJ; Pantanowitz L; Aboulafia DM
    AIDS Read; 2004 May; 14(5):236-8, 243-4, 251-3. PubMed ID: 15199854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [AIDS associated cancers in the era of highly active antiretroviral therapy (HAART)].
    Tserenpuntsag B; Kołacińska A; Jabłonowska E
    Przegl Epidemiol; 2007; 61(3):529-34. PubMed ID: 18069390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of Kaposi's sarcoma in resource-limited settings in the era of HAART.
    Lynen L; Zolfo M; Huyst V; Louis F; Barnardt P; Van de Velde A; De Schacht C; Colebunders R
    AIDS Rev; 2005; 7(1):13-21. PubMed ID: 15875657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [HAART and changes of epidemiology, treatment and prognosis of HIV-positive patients with Kaposi's sarcoma and lymphoma].
    Gabarre J; Bossi P
    Bull Cancer; 2003 May; 90(5):419-25. PubMed ID: 12850765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncologists scout new directions for KS and lymphoma therapies.
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1995 Jun; 1(5):10-4. PubMed ID: 11362600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Kaposi's sarcoma during HIV infection in Morocco (apropos of 50 cases)].
    Chakib A; Hliwa W; Marih L; Himmich H
    Bull Soc Pathol Exot; 2003 May; 96(2):86-9. PubMed ID: 12836521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kaposi' s sarcoma in HIV-positive patients: the state of art in the HAART-era.
    La Ferla L; Pinzone MR; Nunnari G; Martellotta F; Lleshi A; Tirelli U; De Paoli P; Berretta M; Cacopardo B
    Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2354-65. PubMed ID: 24065230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New treatment for KS offers options for therapy.
    AIDS Alert; 1996 Feb; 11(2):21-2. PubMed ID: 11363236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.